54 Participants NeededMy employer runs this trial

Arthrocentesis for ACL Tears

(ASPIRATE Trial)

Recruiting at 1 trial location
MK
Overseen ByMichael Keller
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Ohio State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The ASPIRATE trial is a randomized controlled trial evaluating the effects of pre- and post-operative knee joint aspiration in patients with an ACL injury. The study aims to determine if removing knee joint fluid can mitigate the increasing inflammation after surgery, reduce quadriceps atrophy, improve short-term pain, enhance functional recovery, and lower long-term rates of post-traumatic knee osteoarthritis.

Who Is on the Research Team?

Jv

Jelle van der List, MD, PhD

Principal Investigator

Ohio State University

Are You a Good Fit for This Trial?

This trial is for people who have recently injured or torn their ACL (a major knee ligament) and are planning to have surgery. Participants should not have other serious injuries, infections, or health conditions that could affect the study.

Inclusion Criteria

I am between 15 and 40 years old.
I have a confirmed ACL tear and chose reconstruction with a QT or BPTB autograft.
My aspiration happened within 30 days of my injury.

Exclusion Criteria

History of illicit drug or alcohol abuse
No mastery of the English language
I am afraid of needles or do not want joint fluid removed.
See 14 more

What Are the Treatments Tested in This Trial?

Interventions

  • Knee Aspiration

Trial Overview

The study compares two groups: one group has fluid removed from their knee joint before and after ACL surgery (knee aspiration), while the other group does not. The goal is to see if this helps with pain, swelling, muscle strength, and recovery.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: AspirationExperimental Treatment1 Intervention
Group II: No AspirationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio State University

Lead Sponsor

Trials
891
Recruited
2,659,000+